Gcpred 8 Tablet contains Methylprednisolone 8 mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory, allergic, and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, asthma, and allergic reactions. Methylprednisolone works by inhibiting multiple inflammatory cytokines, thereby reducing inflammation and immune system activity. This medication is also utilized in the treatment of certain endocrine disorders and as part of therapy for some hematologic and neoplastic diseases. Gcpred 8 Tablet should be administered under strict medical supervision, with dosage tailored to the individual patient’s condition and response. Common side effects may include gastrointestinal disturbances, increased susceptibility to infections, mood changes, and elevated blood glucose levels. Long-term use requires monitoring for potential adverse effects such as osteoporosis, adrenal suppression, and cataracts. Patients should avoid abrupt discontinuation to prevent withdrawal symptoms and adrenal insufficiency. Caution is advised in patients with diabetes, hypertension, peptic ulcer disease, or psychiatric disorders. Gcpred 8 Tablet is contraindicated in systemic fungal infections and hypersensitivity to corticosteroids. Proper adherence to prescribed dosage and regular follow-up are essential to maximize therapeutic benefits while minimizing risks.